Neurocrine Biosciences Inc

Connor, Clark & Lunn Investment Management Ltd. NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

246,289

Value ($000)

34,931

Weight

0.1%

2020 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	34,931	0.1%	246,289	12/31/2025
2025 Q3	11/13/2025	39,463	0.1%	281,113	9/30/2025
2025 Q2	8/7/2025	31,251	0.1%	248,633	6/30/2025
2025 Q1	5/12/2025	6,179	0.0%	55,865	3/31/2025
2024 Q4	2/10/2025	8,679	0.0%	63,582	12/31/2024
2024 Q3	11/8/2024	1,980	0.0%	17,186	9/30/2024
2024 Q2	8/9/2024	307	0.0%	2,230	6/30/2024
2023 Q4	2/9/2024	3,679	0.0%	27,921	12/31/2023
2023 Q3	11/13/2023	7,883	0.0%	70,069	9/30/2023
2023 Q2	8/10/2023	15,302	0.1%	162,269	6/30/2023
2023 Q1	5/10/2023	24,416	0.1%	241,216	3/31/2023
2022 Q4	2/10/2023	21,094	0.1%	176,604	12/31/2022
2022 Q3	11/10/2022	20,956	0.1%	197,308	9/30/2022
2022 Q2	8/5/2022	20,929	0.1%	214,697	6/30/2022
2022 Q1	5/12/2022	19,650	0.1%	209,599	3/31/2022
2021 Q4	2/10/2022	4,436	0.0%	52,087	12/31/2021
2021 Q1	5/13/2021	446	0.0%	4,586	3/31/2021
2020 Q3	11/12/2020	1,010	0.0%	10,499	9/30/2020